Canary Capital expands its ETF selection with new INJ filing

Staked Injective ETF Filed by Canary Capital: Can INJ Reach $16?

The fund would hold Injective Protocol’s native token, INJ, and stake a portion of it via approved validator providers Injective’s price surged up to 14% following the news, currently hovering around $14 Canary Capital has similar filings underway for assets such as Solana, XRP, Hedera, SUI, and Tron Canary Capital, a Delaware-based asset manager, has filed an S‑1 registration with the US SEC for the Canary Staked INJ ETF. This marks the first-e…

Recent Injective (INJ) Updates (as of July 18, 2025) News ETHNews

Injective Mainnet 2.0 improves speed, enhances security, and supports perpetual futures, options, and decentralized spot order book infrastructure. The platform’s cross-chain bridge Peggy 2.0 enables seamless asset transfers across Ethereum, Solana, and Cosmos networks without intermediaries. Injective Labs has expanded its developer and business operations team to over 50 members, including former professionals from centralized exchanges, finte…

Canary Capital Files For Staked Injective ETF - Can INJ Target $16 Next? - Data Intelligence

Key Takeaways Canary Capital files for the first-ever Injective staking ETF. The DEX volume has also increased in the last 24 hours, while TVL almost hit 2025 highs. But how high can INJ rise after these triggers? Injective [INJ] rose by about 8% in the last 24 hours as of press time, with an unlocked market cap of $1.45 billion as per CoinMarketCap. Meanwhile, the AI crypto coin is getting more exposure in the U.S. market. Canary Capital files …

Canary continues altcoin ETF strategy with application to launch Injective fund with staking

Canary Capital has filed with the U.S. Securities and Exchange Commission to launch the first-ever staked Injective (INJ) exchange-traded fund, aiming to provide institutional investors with regulated access to native on-chain yield. The proposed Canary Staked INJ ETF would actively stake its INJ holdings on the Injective proof-of-stake network, passing staking rewards, currently estimated at 10% to 12% annually, directly to shareholders. It als…

Canary Files for Staked Injective ETF as Altcoin Funds Pick Up Steam

Canary Capital is back with another ETF proposal, this time targeting Injective. The New York-based firm has filed with the SEC to launch a fund that tracks INJ while also staking it. The idea is simple. Instead of just following Injective’s price, the ETF would also collect staking rewards along the way. Investors could earn yield automatically, with no wallets, no validators, and no crypto know-how needed. Why Injective and Why Now Injective i…

Canary Files for Staked Injective ETF as Interest in Altcoin Funds Grows - WorldNL Magazine

In brief Canary has filed with the SEC to debut a staked Injective ETF. INJ is the native token of Injective, a layer-1 blockchain. The filing is one of several requests by issuers and exchanges to make crypto-based ETFs with staking available to U.S. investors. Canary Capital applied for a staked Injective exchange-traded fund, according to a filing with the U.S. Securities and Exchange Commission on Thursday, further evidence of issuers effort…